Direct Detection of Burkholderia cepacia in Susceptible Pharmaceutical Products Using Semi-Nested PCR

References

1. 1.↵
   1. Torbeck L.,
   2. Raccasi D.,
   3. Guilfoyle D. E.,
   4. Friedman R. L.,
   5. Hussong D.

   Burkholderia cepacia: This Decision Is Overdue. PDA J. Pharm. Sci. Technol. 2011, 65 (5), 535–543.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Sousa S. A.,
   2. Ramos C. G.,
   3. Leitao J. H.

   Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int. J. Microbiol. 2011, doi: 10.1155/2011/607575.
3. 3.↵
   1. Miller S. C.,
   2. LiPuma J. J.,
   3. Parke J. L.

   Culture-based and non-growth-dependent detection of the Burkholderia cepacia complex in soil environments. Appl. Environ. Microbiol. 2002, 68 (8), 3750–3758.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Murray P.,
   2. Baron E.,
   3. Pfaller M.,
   4. Tenover F.,
   5. Yolken R.

   1. Gilligan P.,
   2. Whittier S.

   Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamona and Adidoboras. In Manual of Clinical Microbiology, Murray P., Baron E., Pfaller M., Tenover F., Yolken R., Eds.; American Society for Microbiology: Washington, DC, 1999; p 526.
5. 5.↵
   FDA Guide to Inspections of Microbiological Pharmaceutical Quality Control Laboratories, 1993.
6. 6.↵
   United States Pharmacopoeia. USP <61> Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests. United States Pharmacopeial Convention: Rockville, MD, 2008.
7. 7.↵
   United States Pharmacopoeia. USP <62> Microbiological Examination of Non-Sterile Products: Tests for Specified Microorganisms. United States Pharmacopeial Convention: Rockville, MD, 2008.
8. 8.↵
   1. Jimenez L.

   Microbial Contamination Control in the Pharmaceutical industry; Marcel Dekker: New York, 2004.
9. 9.↵
   U.S. Department of Health and Human Services, Office of Compliance, Bureau of Drugs. “Letter to the pharmaceutical industry, RE: Validation and control of deionized water systems”, August 1981.
10. 10.↵
    1. Vanlaere E.,
    2. Baldwin A.,
    3. Gevers D.,
    4. Henry D.,
    5. De Brandt E.,
    6. Lipuma J. J.,
    7. Mahenthiralingam E.,
    8. Speert D. P.,
    9. Dowson C.,
    10. Vandamme P.,
    11. Taxon K.

    A complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int. J. Syst. Evol. Microbiol. 2002, 59, 102–111.

    OpenUrl
11. 11.↵
    1. Henry D. A.,
    2. Mahenthiralingam E.,
    3. Vandamme P.,
    4. Coenye T.,
    5. Speert D. P.

    Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 2001, 39 (3), 1073–1078.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Vandamme P.,
    2. Dawyndt P.

    Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst. Appl. Microbiol. 2011, 34 (2), 87–95.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Mahenthiralingam E.,
    2. Bischof J,
    3. Byrne S. K.,
    4. Radomski C,
    5. Davies J. E.,
    6. Av-Gay Y.,
    7. Vandamme P.

    DNA-based diagnostic approches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 2000, 38, 3165–3173.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Moore J. E.,
    2. Xu J.,
    3. Millar B. C.,
    4. Crowe M.,
    5. Elborn J. S.

    Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from the sputum of patients with cystic fibrosis. J. Microbiol. Methods. 2002, 49 (2), 183–191.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Moore J. E.,
    2. Millar B. C.,
    3. Jiru X.,
    4. McCappin J.,
    5. Crowe M.,
    6. Elborn J. S.

    Rapid characterization of the genomovars of the Burkholderia cepacia complex by PCR–single stranded conformational polymorphism (PCR-SSCP) analysis. J. Hosp. Infect. 2001, 48 (2), 129–134.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    United States Pharmacopoeia. USP <61> Microbiological Examination of Non-Sterile Products: Microbial Enumeration Tests. United States Pharmacopeial Convention: Rockville, MD, 2014.
17. 17.↵
    United States Pharmacopoeia. USP <62> Microbiological Examination of Non-Sterile Products: Tests for Specified Microorganisms. United States Pharmacopeial Convention: Rockville, MD, 2014.
18. 18.↵
    United States Pharmacopoeia. USP <1227> Validation of Microbial Recovery from Pharmaceutical Articles. United States Pharmacopeial Convention: Rockville, MD, 2008.
19. 19.↵
    1. Vandamme P.

    Burkholderia cepacia: Pandora's Box redefined. BCCM News, 2001, 9, 2–3.

    OpenUrl
20. 20.↵
    1. Carson L.,
    2. Favero M. S.,
    3. Bond W. W.,
    4. Peterson N. J.

    Morphological, biochemical, and growth characteristics of Pseudomonas cepacia from distilled water. Appl. Microbiol. 1973, 25 (3), 476–483.

    OpenUrlPubMedWeb of Science
21. 21.
    1. Luigi C.

    Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol. 2006, 14 (6), 277–286.

    OpenUrlCrossRefPubMedWeb of Science